FIELD: medicine.
SUBSTANCE: general clinical and immunological parameters are evaluated. If observing the decrease of total T-lymphocytes (CD2+) to 61% and less, T-helper/inducer (CD4+) count to 31% and less, the increase of the serum immunoglobulin IgG concentration to 16.7 g/l and more, the level of circulating immune complexes to 133 standard units and more, a neurotic, clinically favourable PTSD version transition to a pathologically characterised version formed as a version of unfavourable course of PTSD.
EFFECT: method extends the range of products for prediction of an unfavourable course of posttraumatic stress disorder.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE FLOW OF POST-TRAUMATIC STRESS DISORDERS | 2006 |
|
RU2310202C1 |
| METHOD FOR PREDICTION OF CHRONIC COURSE OF NEUROTIC DISORDERS | 2009 |
|
RU2421727C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF SOMATOFORM DISORDERS | 2015 |
|
RU2578966C1 |
| METHOD FOR PREDICTION OF FORMATION OF ORGANIC PERSONALITY DISORDER | 2011 |
|
RU2488118C1 |
| METHOD OF THE PANIC DISORDER FORMING RISK PREDICTING AT THE EARLY STAGE OF DISEASE | 2016 |
|
RU2644309C1 |
| METHOD OF POSTTRAUMATIC STRESS-INDUCED INJURY (PTSI) DIAGNOSTICS | 2007 |
|
RU2328977C2 |
| METHOD OF PREDICTING PROTRACTED COURSE OF ADAPTATION DISORDER IN WOMEN WITH HYPOTHYROIDISM | 2023 |
|
RU2813697C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR TREATMENT OF CHRONIC PAIN SYNDROMES, FORMED ON BASIS OF POST-TRAUMATIC STRESS DISORDER, COMBINED WITH COMBAT BRAIN INJURY EFFECTS | 2016 |
|
RU2643583C1 |
| METHOD FOR PREDICTING THE FLOW OF DEPRESSIVE REACTIONS | 2003 |
|
RU2239190C1 |
